ABVC BioPharma Inc. (ABVC)
Market Closed
15 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM) Primary $
0. 93
-0.09
-8.5294%
$
26M Market Cap
- P/E Ratio
- Div Yield
104,800 Volume
- Eps
$ 1.02
Previous Close 
Want to track ABVC and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
ABVC BioPharma Inc. (ABVC) Statistics
Valuation metrics
Market Cap 26M
Enterprise value 27.73M
Trailing P/E (ttm) -3.39
Forward P/E -
PEG ratio 0.05
Price/Sales (ttm) -32.67
Price/Book (mrq) 2.53
Enterprise Value/Revenue -34.84
Enterprise Value/EBITDA -3.58
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 48.35K
Average volume (90 days) 66.62K
Price summary
52-Week low 0.71
52-Week high 3.07
Beta -
50-Day moving average 1
200-Day moving average 1.24
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:10
Last split Date 25 Jul 2023
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 9.93%
Operating margin 9.19%
Operational effectiveness
Return on assets -0.41%
Return on equity -0.71%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -0.03
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.17
Current ratio (mrq) 0.07%
Book value per share (mrq) 0.47
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
